Tariff Turbulence — How Proposed Trade Policies Could Create Financial Whiplash for Hospital Systems
In recent months, the healthcare industry has been sounding the alarm over a new set of financial headwinds: tariffs. With the Trump administration proposing broad tariffs on imported medical supplies, pharmaceuticals, and equipment—some already enacted—hospitals and health systems are bracing for rising costs, procurement delays, downstream impacts on patients, and continued uncertainty. Even if tariffs are used for negotiating purposes or are not implemented or rolled back, hospitals will still need to manage this volatility—and transparency is key.
At a time when many hospitals are still recovering from pandemic-era challenges, these policy shifts threaten to reshape the economics of care delivery in ways that could be hard to absorb.
Cost Pressures Are Already Mounting
- • 82% expect at least a 15% increase in hospital and health system costs due to tariff-related expenses.
- • 69% of respondents anticipate a 10% or greater increase in pharmaceutical prices, largely driven by tariffs on Chinese imports — a country that supplies the majority of active pharmaceutical ingredients (APIs), according to a US. FDA report.
Tight Margins, Tough Decisions
Unlike other sectors that can offset costs through pricing flexibility or reduced labor spend, hospitals often operate on extremely narrow margins. In the same Black Book survey:
- • 90% of hospital finance leaders said they plan to pass increased costs on to payers and patients via higher service charges.
- • 94% of healthcare administrators said they anticipate delaying equipment purchases or upgrades to avoid further strain on budgets.
For health systems already grappling with inflation and evolving reimbursement structures, tariffs risk compounding existing financial stressors—especially in areas where costs are challenging to measure in the first place. Hospital suppliers will be incentivized to pass costs on to the hospital. Hospitals with strong vendor contracts may have temporary reprieve, but vendors will be incentivized to pass on their increased costs however they can—expect additional fees, pushing uncontracted items, and ultimately more challenging contract negotiations.
Supply Chain Stability at Risk
Tariffs don’t just make goods more expensive — they also risk destabilizing supply chains for critical medical products.
- • 81% of medical equipment manufacturers surveyed predict longer lead times and product shortages, caused by increased production costs and import restrictions.
- • While 27% of supply leaders are considering alternative suppliers, 92% of pharmaceutical manufacturers warn that switching vendors may cause delays due to regulatory hurdles and quality assurance processes (Black Book Market Research, 2025).
This disruption may be particularly harmful for hospitals that already struggle to stock essential items or operate in rural markets with fewer procurement options.
The Patient Perspective: Higher Bills, Delayed Care
The ultimate cost burden may land—as it often does—on patients. If hospitals are unable to absorb higher expenses, many will pass them along in the form of higher charges, increased premiums, or postponed care—especially for elective procedures.
- • 84% of payers surveyed expect higher claims costs, and
- • 48% anticipate rising insurance premiums in the next 12 months due to supply chain-related expenses (Black Book Market Research, 2025).
These ripple effects could increase the number of underinsured or uninsured patients, particularly those requiring expensive therapies or procedures—further driving up uncompensated care.
What Comes Next?
While the future of tariff legislation remains uncertain, hospital systems must begin proactively planning for instability. Rather than reacting to financial shocks as they arise, leading organizations are taking strategic steps to build more resilient supply chains:
- • Conduct a comprehensive tariff impact assessment. Map exposure across high-spend product categories—including implants, pharmaceuticals, and diagnostic tools—and identify suppliers most at risk of cost volatility or disruption.
- • Invest in advanced supply chain management platforms. Without timely visibility into current spend—especially in high-cost, opaque cost centers—hospitals are flying blind. Modern tools can help organizations trace where every dollar is going, model the impact of tariff changes, and build contingency plans. Good software enables spend control, supplier performance tracking, and more informed contract negotiations.
- • Establish tiered supplier strategies and contract safeguards. Hospitals should evaluate their vendor base for over-concentration in tariff-exposed geographies and consider diversifying suppliers. In parallel, they can renegotiate contracts to include escalation clauses, pricing benchmarks, and protections against surcharges on uncontracted items.
- • Rebuild inventory resilience. Strategically building buffer stock of critical items—especially those with limited domestic availability—can mitigate disruption. Inventory strategies should be tailored based on product criticality, shelf life, and volatility risk.
- • Model financial scenarios and reforecast often. Hospitals should regularly update their cost projections based on shifting geopolitical signals, ensuring that budgets, service line pricing, and reimbursement models reflect real-time risk.
- • Create a patient affordability task force. Understanding how cost increases could impact access—especially for elective and high-cost procedures—is essential. Hospitals that proactively monitor affordability outcomes can better protect vulnerable populations and avoid unanticipated equity gaps.
By strengthening their operational foundations today, health systems can move from reactive cost-cutting to proactive risk management—and turn supply chain transparency into a competitive advantage.
Preparing for a New Era of Healthcare Supply Chain Risk
Tariffs may be rooted in geopolitics, but their effects are deeply felt at the point of care. For hospitals, managing these evolving pressures will require a renewed focus on supply chain transparency, financial flexibility, and patient-first planning.
In Part 2, we’ll zoom in on one of the most tariff-sensitive areas of the healthcare supply chain: Bill-Only medical devices and explore how policy changes may further complicate this already high-cost, low-transparency category.
"*" indicates required fields